About Iduron

Iduron is a specialised glycosaminoglycan (GAG) company, providing a unique and exciting range of GAG products. These products are vital for academic research and development, as well as for the pharmaceutical industry.

Iduron’s main goal is to support the fast-growing area of GAG-based scientific research by offering a complete selection of reagents, related products, and expert guidance.

Elevating Sensitivity in Growth Factor Quantification

Iduron sought to develop a new generation of assay plates that would offer unparalleled sensitivity for quantifying specific growth factors. These specialised plates were aimed for critical applications primarily within discovery research, where precision and reliability are important.

While Iduron had the innovative vision for these products, they required a partner with advanced coating capabilities and a rigorous quality assurance process to help transform their concept into a high-performance, market-ready solution. The goal was to create plates that would outperform existing options in sensitivity and provide researchers with more accurate and actionable data.

TekCyte’s Solution: Expert Coating and Collaborative Enhancement

We partnered closely with Iduron, leveraging our state-of-the-art facility and extensive expertise in surface modification. Our role was to further develop these specialised plasma-coated plates. Through a meticulous and controlled coating process, we applied a proprietary plasma coating designed to optimise the plate surface for the specific assay requirements.

Our collaborative approach extended beyond just application. We worked hand-in-hand with Iduron’s technical team, providing ongoing insights and conducting rigorous testing to validate the coating’s integrity, consistency, and, most importantly, its impact on assay performance.

This iterative process of coating, testing, and refining ensured that the final product not only met but exceeded the stringent sensitivity requirements set by Iduron. This level of engagement exemplifies our commitment to enhancing the value of our partners’ products through our specialised capabilities.

The Results: Unmatched Performance and a Lasting Partnership

The collaboration between TekCyte and Iduron resulted in the successful development and commercialisation of highly sensitive plasma-coated plates. These plates are now a valuable asset for Iduron’s customers in discovery research, enabling them to quantify growth factors with a level of precision that Iduron proudly states surpasses that of competitors’ offerings.

This success is a testament to our technical capabilities and the strength of our partnership model. The plates are coated exclusively at TekCyte’s facility, and their sales are managed by Iduron through a mutually beneficial profit-sharing arrangement. This long-term, trust-based collaboration shows TekCyte’s capacity to be more than just a service provider. We often become an integral part of our partners’ value chain, contributing directly to their product’s success and market differentiation.

Building Trust Through Proven Performance

The Iduron case study clearly shows how TekCyte’s special coating and testing services make products even better and more useful. Our true partnership model helps us improve existing products, allowing our clients to offer market leading solutions. By working together and sharing our unique skills, we help our partners reach their business and scientific goals.

TekCyte is the partner you can trust for special coating, testing, and making your products better. We’re ready to help you improve your products and achieve even greater success in the market.

Alyra Biotech

Alyra Biotech is a pioneering company dedicated to advancing therapeutic solutions to improving the management of pain and wellbeing in women. They approached TekCyte with a visionary concept for a medical device that required a precise drug release profile.

Alyra Biotech sought a partner with robust research and development capabilities to transform this product concept into a tangible, effective product and quality manufacturing capabilities for human clinical use.

The Dual Challenge: Precision & Scalability

Alyra Biotech had two main challenges to solve to make their new medical device a reality. First, they needed to design the device to release the drug exactly as required while also fitting all the required physical specifications. This meant balancing complicated drug science with practical engineering.

Second, they faced the challenge of manufacturing the device on a large scale. They needed a manual production process that could reliably create many devices of the same high quality, with patient safety in mind. Ensuring every single device was identical was crucial for using them in clinical trials.

TekCyte’s Integrated Solution

TekCyte leveraged its strong R&D skills to help Alyra Biotech achieve its initial goal. Our team carefully tested different ways to formulate drug-release compounds. TekCyte worked closely with Alyra Biotech to refine the delivery method of the drug until it achieved the exact release profile required. This teamwork successfully turned Alyra Biotech’s complex idea into a working and effective solution.

After this, we applied our expertise in designing the manufacturing tools required to meet the exacting dimensions of the final medical device.

Driving Future Success

Thanks to this successful teamwork, TekCyte manufactured the medical device that Alyra Biotech required for its very important first Phase I clinical trial. The device worked exceptionally well, and the trial was expanded to a second Phase I trial, including even more patients.

We continue to be an essential partner for Alyra Biotech’s medical device for this larger clinical trial phase. Supporting Alyra Biotech’s growth and helping them bring new innovative treatments to patients.